A systematic review on treatment-related mucocutaneous reactions in COVID-19 patients
COVID-19 환자의 치료 관련 점막 피부 반응에 대한 체계적인 검토
Article
[키워드] Adverse drug reaction
Adverse drug reactions
adverse effect
adverse effects
Adverse reaction
AGEP
Anti-viral
antibiotic
Antibiotics
antimalarial
antimalarial drug
Antimalarial drugs
Antiviral
article
articles
Azithromycin
Better
biologic
clinical trials
cohorts
Combination
Corona virus
coronavirus
COVID-19
COVID-19 patient
covid-19 therapies
COVID-19 treatments
Cutaneous
cutaneous drug reactions
database
databases
Dermatology
drug
drug eruption
drug eruptions
drug induced
drug reaction
drug usage
enoxaparin
eruption
Favipiravir
Frequency
HCQ
highest
human coronavirus
Hydroxychloroquine
induce
initial
Jak
JAK inhibitor
Janus kinase
Janus kinase inhibitor
Kinase inhibitor
less
Lopinavir
Lopinavir/ritonavir
maculopapular rashe
maculopapular rashes
management
MOST
mucocutaneous
mucosal
novel human coronavirus (SARS-CoV-2)
occur
pandemic
potentially life-threatening
prevalent
rashes
reaction
Reactions
Ritonavir
Side effect
Side effects
skin
skin reactions
steroid
Steroids
syndrome
systematic review
targeted therapy
TNF-α
TNF-α inhibitor
Tocilizumab
Treatment
treatment-induced
treatment-reaction
treatment-related.
Type
Usage
Vasculitis
[DOI] 10.1111/dth.14662 PMC 바로가기 [Article Type] Article
[DOI] 10.1111/dth.14662 PMC 바로가기 [Article Type] Article